ClinicalTrials.gg
Not yet recruitingNCT05373342PRINCEUpdated Apr 9, 2026

Feasibility Study to Evaluate the Role of a Novel Device in Childbirth

An observational study in Surgical Item, Retained and Childbirth, sponsored by The Royal Wolverhampton Hospitals NHS Trust. Not yet recruiting. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-09.

Sponsored by The Royal Wolverhampton Hospitals NHS Trust · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
70
Ages
18 Years and older
Sex
Female
01

Study summary

Accidentally retained surgical items or swabs are well-recognised errors that result in adverse consequences for patients. This error is one of the commonest "Never Events" - patient safety incidents that are considered preventable. Although uncommon, these incidents can have devastating consequences. Retained surgical items have 70% re-interventions, reaching 80% morbidity and 35% mortality.

Swabs or sponges are like small towels that soak up blood and body fluids so that the surgeon can visualise the operating area effectively. Swabs are used in all areas of surgery which include operations on the tummy, chest, limbs. They are also used in the vagina during childbirth, to assess for tears and to minimise blood oozing from the vagina.

The common risk factors for this error are out of hours surgical or childbirth procedures, multiple handovers in the care of the patient, raised BMI (Body Mass Index) and unplanned change to the operative intervention.

As the name suggests, a 'never event' should never happen in the first place. Never. Unfortunately, this is not the case. Incidents involving surgical swabs being left behind, particularly during a caesarean section or a perineal repair following a vaginal birth, are still happening despite over 100 years of institutional awareness of the problem and tentative solutions being implemented in clinical practice.

never-event incidents involving retained surgical swabs are a widespread problem affecting healthcare systems worldwide. It is therefore reasonable to ask the question: why are surgical swabs being left behind and what can be done to prevent this from happening?

02

Conditions studied

  • Surgical Item, Retained
  • Childbirth

Browse trials for

03

In context

Foreign Bodies

29 studies on the registry are indexed under Foreign Bodies; 8 are open to participants now.

This study's planned enrollment of 70 is below the median of 100 across 19 observational studies indexed under Foreign Bodies.

Browse Foreign Bodies studies →

Lead sponsor

The Royal Wolverhampton Hospitals NHS Trust is the lead sponsor of 51 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Pregnant women during labour

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Midwifery lead and consultant lead patient older than 18 years.
  • Consented to participation after an informed choice.

Exclusion criteria

Exclusion Criteria:

  • Under 18 years of age

Antenatal (before labour):

  • Patients who have a high risk of expected/unexpected maternal, fetal or neonatal deterioration such that during birth, the focus of attention would be towards safe patient care and observation required for using the swab-counter device system would not be possible such as :
  • Patients who are seriously unwell and require high dependency care.
  • Maternal cardiac conditions
  • Severe pre-eclampsia
  • Fetal anomalies where neonatal deterioration is expected (These will be relatively rare conditions where the doctor/midwife would decide to not recruit the patient)

Intrapartum and postpartum factors:

  • Patient having an emergency Caesarean section instead of a vaginal birth due to maternal or fetal indication.
  • Eclampsia (seizure/fitting in labour or after delivery)
  • Maternal cardiac conditions requiring high dependency care
  • Severe sepsis requiring high dependency care
  • Fetal anomalies where neonatal deterioration is expected
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
70 participants (estimated)
Patient registry
No

Groups and cohorts

  • iCount Device

    A novel external device which can count the swabs and surgical tampons used during childbirth in an objective and validated manner.

    Device: iCount system assembled with swabs

  • User Feedback Survey

    Feedback will be taken from 20 users including midwives/ doctors. Users will be emailed an online survey or given the same survey as a printout to complete. All 20 users will also then also be approached to have a semi-structured interview. 10 of the users who first express interest will be interviewed.

Interventions

  • DeviceiCount system assembled with swabs

    Designed as single use. Intended purpose - To be used to count swabs and tampons after childbirth in an objective manner. This is intended to be used in women during and after childbirth.

06

What researchers measure

Primary outcomes

  1. Rate of device count accuracy (conspicuity of spotting a missing swab) measured via staff questionnaire feedback

    Time frame: 12 months

  2. User experience about general look and feel and user satisfaction (overall perception) measured via staff questionnaire feedback

    Time frame: 12 months

  3. User perception about the confidence about the accuracy of the count with use of the device and thoughts about intention to use, if available (functionality) measured via staff questionnaire feedback

    Time frame: 12 months

  4. User perception about the ease of learning of how to use the device measured via staff questionnaire feedback

    Time frame: 12 months

  5. User perception of how device works within current system measured via staff questionnaire feedback

    Time frame: 12 months

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05373342
Lead sponsor
The Royal Wolverhampton Hospitals NHS Trust
Responsible party
Sponsor
First posted
May 13, 2022
Start date
Sep 2026 (estimated)
Primary completion
Sep 2027 (estimated)
Completion
Sep 2027 (estimated)
Last update
Apr 9, 2026

Study contacts

Aditi Desai
Contact
aditidesai@nhs.net
01902695166
Aditi Desai
principal investigator · The Royal Wolverhampton NHS Trust

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion